Glenn E Leslie, RPH | |
911 Rainbow Dr, Gadsden, AL 35901-5309 | |
(256) 547-4479 | |
(256) 549-0577 |
Full Name | Glenn E Leslie |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 911 Rainbow Dr, Gadsden, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699816785 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 11682 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Glenn E Leslie, RPH 911 Rainbow Dr, Gadsden, AL 35901-5309 Ph: (256) 547-4479 | Glenn E Leslie, RPH 911 Rainbow Dr, Gadsden, AL 35901-5309 Ph: (256) 547-4479 |
News Archive
Scientists at the Freie Universität Berlin have come one step closer to unraveling the molecular basis of learning. A team led by neurobiologist Bjorn Brembs has discovered the first gene for operant conditioning in the fruit fly Drosophila.
Aging-US published "Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma" which reported that there is still a lack of comprehensive analysis of the circular RNA -long non-coding RNA -miRNA-mRNA ceRNA network in hepatocellular carcinoma.
The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).
Despite major research advances over the last several decades that have helped deliver improved therapeutic options for leukemia, the condition remains deadly. Specialists are in need of new options to help diagnose the condition earlier and new therapies that will extend patients' lives. New research addressing important updates on the diagnosis and treatment of leukemia will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model study undertaken by researchers at Helmholtz Zentrum München in cooperation with the Munich biotech company Trion Research.
› Verified 8 days ago
Mrs. Jennifer Louise Morrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 319 Broad St, Gadsden, AL 35901 Phone: 256-543-9000 Fax: 256-543-9005 | |
Mr. Wendell Ray Hicks Ii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-494-4047 | |
Jeffrey Burke Yother Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2608 W Meighan Blvd, Gadsden, AL 35904 Phone: 256-543-9709 | |
Dr. Charles Vondrea Vawters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 806 Hoke St, Gadsden, AL 35903 Phone: 256-492-4807 | |
Mrs. Ginger Brown Barron, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 851 Goodyear Ave, Gadsden, AL 35903 Phone: 256-456-5850 Fax: 256-467-3585 | |
Mr. Zachary John Hefner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 107 E Meighan Blvd, Gadsden, AL 35903 Phone: 256-547-4717 | |
Ali Mitchell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 340 E Meighan Blvd, Gadsden, AL 35903 Phone: 256-547-8928 |